JAC Advance Access originally published online on August 13, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 52, 514-517
© 2003 The British Society for Antimicrobial Chemotherapy
Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides
Infectious Diseases Research Laboratory, Infectious Diseases Division, Hospital Universitari Vall dHebron, Universitat Autònoma de Barcelona, Avda. Vall dHebron, 119129, 08035 Barcelona, Spain
Received 24 March 2003; returned 25 April 2003; revised 4 June 2003; accepted 6 June 2003
Objective: This study tests the usefulness of ceftriaxone combined with ampicillin as an alternative to ampicillin plus gentamicin for the treatment of experimental endocarditis due to Enterococcus faecalis without high-level resistance to aminoglycosides. It also determines whether adding ceftriaxone to ampicillin and gentamicin increases the effectiveness against experimental enterococcal endocarditis resulting from E. faecalis.
Methods: Animals with catheter-induced endocarditis were infected intravenously with 108 cfu of the EF91 strain of E. faecalis and were treated for 3 days with ampicillin 2 g every 4 h administered as human-like (H-L) pharmacokinetics, plus gentamicin 1 mg/kg every 8 h H-L, or ceftriaxone 2 g every 12 h H-L alone or combined with gentamicin 6 mg/kg every 24 h administered subcutaneously.
Results: The results of therapy for experimental endocarditis resulting from EF91 showed that the combination of ampicillin plus ceftriaxone was as effective as ampicillin plus gentamicin. The triple combination did not improve on the overall efficacies of the two-drug combinations.
Conclusions: Because of its lower nephrotoxicity, ampicillin plus ceftriaxone may be a useful alternative therapy for E. faecalis endocarditis in selected patients.
Keywords: bacteria, intravascular infections, animal models, antibiotic combinations
* Corresponding author. Tel: +34-93-4894033; Fax: +34-93-2746057; E-mail: gavalda{at}hg.vhebron.es
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Euba, J. Lora-Tamayo, O. Murillo, S. Pedrero, J. Cabo, R. Verdaguer, and J. Ariza Pilot Study of Ampicillin-Ceftriaxone Combination for Treatment of Orthopedic Infections Due to Enterococcus faecalis Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4305 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gavalda, O. Len, B. Almirante, and A. Pahissa Ampicillin plus Ceftriaxone for High-Level Aminoglycoside-Resistant Enterococcus faecalis Endocarditis Ann Intern Med, February 5, 2008; 148(3): 243 - 243. [Full Text] [PDF] |
||||
![]() |
J. Gavalda, O. Len, J. M. Miro, P. Munoz, M. Montejo, A. Alarcon, J. de la Torre-Cisneros, C. Pena, X. Martinez-Lacasa, C. Sarria, et al. Brief Communication: Treatment of Enterococcus faecalis Endocarditis with Ampicillin plus Ceftriaxone Ann Intern Med, April 17, 2007; 146(8): 574 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hoen Epidemiology and antibiotic treatment of infective endocarditis: an update. Heart, November 1, 2006; 92(11): 1694 - 1700. [Full Text] [PDF] |
||||


